Oculogica

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, Oculogica sits in the upper quartile of US sponsors by registered trial count (#2,411 of 15,742 sponsors by registered trial count).

5 total trials none currently recruiting 5 completed upper quartile by trial count

Oculogica: 5 sponsored US clinical trials, none currently recruiting.

Oculogica sponsors 5 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 5 completed. The most-studied condition in this pipeline is Cerebral Concussion, with 1 trials.

Upper-quartile sponsor footprint

Oculogica sits in the upper quartile of the sponsor corpus (#2,411 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

5 total, page 1 of 1

COMPLETED

Eye Movement Tracking to Detect Impairment Due to Acute Cannabis Intoxication

NCT04799093
COMPLETED

Oculogica Portable EyeBOX Study

NCT05047003
COMPLETED

EyeBOX Concussion Study and Registry

NCT03966404
COMPLETED

Non-invasive Diagnostic for Assessing Elevated Intracranial Pressure

NCT03418753
COMPLETED

Use of Eye Movement Tracking to Detect Oculomotor Abnormality in Traumatic Brain Injury Patients

NCT02776462

Therapeutic Areas

Cerebral Concussion 1
Concussion, Severe 1
Brain Injuries 1
Concussion, Intermediate 1
Craniocerebral Trauma 1
Trauma, Nervous System 1
Concussion, Mild 1
Brain Concussion 1

How the Oculogica archive is shaped

5 indexed studies, none listed as recruiting (0% open); 5 completed (100%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Cerebral Concussion (1 trial), 7 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

Oculogica: archived-pipeline peers nationwide

Peers matched on 5 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

Oculogica sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%5%10%15%20%25% Total trials Recruiting share Oculogica4YouandMeAbbott Rapid DxAccess Business GroupAcera Surgical10xBio22nd Century Group23andMe3-C Institute for Social Development
Oculogica sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Oculogica sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 5 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Oculogica page

5 registered trials is a research-attention snapshot, not an endorsement of Oculogica or any single study.

  • None of Oculogica's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Cerebral Concussion is the condition Oculogica studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cerebral Concussion trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Oculogica pipeline card: 5 registered trials from official public datasets.Report a data error.